2-232130729-T-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001257282.2(DIS3L2):​c.712T>G​(p.Tyr238Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,613,292 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 25 hom. )

Consequence

DIS3L2
NM_001257282.2 missense

Scores

1
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.560
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035758317).
BP6
Variant 2-232130729-T-G is Benign according to our data. Variant chr2-232130729-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 241983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-232130729-T-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0033 (503/152242) while in subpopulation NFE AF= 0.00345 (235/68018). AF 95% confidence interval is 0.00309. There are 1 homozygotes in gnomad4. There are 277 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 25 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIS3L2NM_152383.5 linkc.702+10T>G intron_variant Intron 7 of 20 ENST00000325385.12 NP_689596.4 Q8IYB7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIS3L2ENST00000325385.12 linkc.702+10T>G intron_variant Intron 7 of 20 5 NM_152383.5 ENSP00000315569.7 Q8IYB7-1

Frequencies

GnomAD3 genomes
AF:
0.00331
AC:
503
AN:
152124
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0166
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00345
Gnomad OTH
AF:
0.00527
GnomAD3 exomes
AF:
0.00419
AC:
1038
AN:
247796
Hom.:
5
AF XY:
0.00416
AC XY:
559
AN XY:
134486
show subpopulations
Gnomad AFR exome
AF:
0.000389
Gnomad AMR exome
AF:
0.000853
Gnomad ASJ exome
AF:
0.00627
Gnomad EAS exome
AF:
0.0000561
Gnomad SAS exome
AF:
0.00320
Gnomad FIN exome
AF:
0.0180
Gnomad NFE exome
AF:
0.00387
Gnomad OTH exome
AF:
0.00300
GnomAD4 exome
AF:
0.00371
AC:
5424
AN:
1461050
Hom.:
25
Cov.:
31
AF XY:
0.00371
AC XY:
2698
AN XY:
726796
show subpopulations
Gnomad4 AFR exome
AF:
0.000359
Gnomad4 AMR exome
AF:
0.000829
Gnomad4 ASJ exome
AF:
0.00616
Gnomad4 EAS exome
AF:
0.0000757
Gnomad4 SAS exome
AF:
0.00310
Gnomad4 FIN exome
AF:
0.0196
Gnomad4 NFE exome
AF:
0.00331
Gnomad4 OTH exome
AF:
0.00351
GnomAD4 genome
AF:
0.00330
AC:
503
AN:
152242
Hom.:
1
Cov.:
32
AF XY:
0.00372
AC XY:
277
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.000481
Gnomad4 AMR
AF:
0.00183
Gnomad4 ASJ
AF:
0.00720
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00125
Gnomad4 FIN
AF:
0.0166
Gnomad4 NFE
AF:
0.00345
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.00375
Hom.:
0
Bravo
AF:
0.00227
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000532
AC:
2
ESP6500EA
AF:
0.00317
AC:
26
ExAC
AF:
0.00387
AC:
467
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00367
EpiControl
AF:
0.00304

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 10, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

DIS3L2: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Perlman syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Oct 11, 2021
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
4.8
DANN
Benign
0.95
Eigen
Benign
-0.98
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.059
N
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-1.0
T
PROVEAN
Benign
0.17
N
REVEL
Benign
0.0080
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.20
T
Polyphen
0.0
B
Vest4
0.36
MVP
0.043
ClinPred
0.0087
T
GERP RS
-3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs184764939; hg19: chr2-232995439; API